BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
BillionToOne (NASDAQ: BLLN) announced it will report fourth quarter and full year 2025 financial results after market close on March 4, 2026.
Rhea-AI Summary
BillionToOne (NASDAQ: BLLN) announced it will report fourth quarter and full year 2025 financial results after market close on March 4, 2026. The company will host a conference call at 1:30 PM PT / 4:30 PM ET the same day and provide a live and archived webcast.
Investors may register to participate in the conference call and access the webcast on BillionToOne's investor relations "Events" page.
Positive
- None.
Negative
- None.
Details
News Market Reaction – BLLN
On Feb 17, the day this news came out, BLLN closed 5.16% above the previous close.
Data tracked by StockTitan Argus for the Feb 17 session.
Key Figures
- 2025 revenue guidance
- $293M–$299M
- Full-year 2025 guidance reiterated on Jan 12, 2026
- 2026 revenue guidance
- $415M–$430M
- Full-year 2026 guidance initiated on Jan 12, 2026
- Guided revenue growth
- 40%–45%
- Implied 2026 growth vs. midpoint of 2025 guidance
- Major holder stake
- 19.6%
- Hummingbird-affiliated ownership of Class A common stock (Schedule 13D)
- Hummingbird purchase price
- $93,673,956.50
- Total cost of preferred and common shares reported in Schedule 13D
- NeoTribe ownership
- 10.6%
- Aggregate beneficial ownership of Class A common stock (Schedule 13G)
- CFO option grant
- 175,000 shares at $11.55
- Stock options vesting over four years from Jan 8, 2025
- CFO option grant
- 75,000 shares at $30.78
- Stock options vesting over four years from Sep 15, 2025
Previous Earnings date Reports
-
Set Q3 2025 earnings release date and conference call details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company plans to release its financial results for fourth quarter and full year ended December 31, 2025 after the market close on Wednesday, March 4, 2026. BillionToOne will host a conference call to discuss its financial results at 1:30pm Pacific Time / 4:30pm Eastern Time the same day.
To participate in the conference call, please register here before the 1:30pm Pacific Time / 4:30pm Eastern Time start. A live and archived webcast will be available on the “Events” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/.
About BillionToOne
Headquartered in Menlo Park, California, BillionToOne is a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit www.billiontoone.com.
Investor Contact
ir@billiontoone.com
Media Contact
billiontoone@moxiegrouppr.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.